Susan Jehangir1, Jujju J Kurian2, Dharshini Selvarajah1, Reju J Thomas2, Andrew J A Holland3. 1. Department of Paediatric Surgery, The Children's Hospital at Westmead, Sydney Medical School, The University of Sydney, Cnr Hawkesbury Road and Hainsworth Street, Westmead, NSW, 2145, Australia. 2. Department of Pediatric Surgery, Christian Medical College, Vellore, Tamil Nadu, India. 3. Department of Paediatric Surgery, The Children's Hospital at Westmead, Sydney Medical School, The University of Sydney, Cnr Hawkesbury Road and Hainsworth Street, Westmead, NSW, 2145, Australia. andrew.holland@health.nsw.gov.au.
Abstract
PURPOSE: Fifty years ago, Bolande described Congenital Mesoblastic Nephroma (CMN) as a benign lesion. Unexpected aggressive clinical behaviors prompted a sub-classification based on histology. Recent molecular genetic evidence has identified the aggressive cellular variant to be the renal manifestation of congenital infantile fibrosarcoma. We submit a reappraisal and analysis of the available literature on recurrent and metastatic CMN. METHODS: An electronic search of PubMed, MEDLINE, EMBASE, and Scopus yielded 38 children with local recurrence and/or metastases. RESULTS: Of the 38 children with local recurrence and/or metastasis, 59% were girls. Median time to recurrence was 6 months (range 1-12 months). The commonest sites of metastases were the lung (39%) and liver (29%). Fifty percent of these children died of disease. The outcome of additional chemotherapy (p = 0.5) did not differ from that of surgery alone. The choice of chemotherapy did not influence the outcome (p = 0.6). CONCLUSIONS: Recurrence and metastasis in cellular CMN are much more common than described earlier and carry a high mortality. Children with cellular and mixed CMN require close clinical and radiological follow-up for a minimum of 12 months after primary surgery. Surgery is the mainstay of the treatment of recurrent and metastatic lesions. Neoadjuvant chemotherapy is recommended only if the lesion is inoperable. Targeted therapy may be an option in treatment of refractory cases.
PURPOSE: Fifty years ago, Bolande described Congenital Mesoblastic Nephroma (CMN) as a benign lesion. Unexpected aggressive clinical behaviors prompted a sub-classification based on histology. Recent molecular genetic evidence has identified the aggressive cellular variant to be the renal manifestation of congenital infantile fibrosarcoma. We submit a reappraisal and analysis of the available literature on recurrent and metastatic CMN. METHODS: An electronic search of PubMed, MEDLINE, EMBASE, and Scopus yielded 38 children with local recurrence and/or metastases. RESULTS: Of the 38 children with local recurrence and/or metastasis, 59% were girls. Median time to recurrence was 6 months (range 1-12 months). The commonest sites of metastases were the lung (39%) and liver (29%). Fifty percent of these children died of disease. The outcome of additional chemotherapy (p = 0.5) did not differ from that of surgery alone. The choice of chemotherapy did not influence the outcome (p = 0.6). CONCLUSIONS: Recurrence and metastasis in cellular CMN are much more common than described earlier and carry a high mortality. Children with cellular and mixed CMN require close clinical and radiological follow-up for a minimum of 12 months after primary surgery. Surgery is the mainstay of the treatment of recurrent and metastatic lesions. Neoadjuvant chemotherapy is recommended only if the lesion is inoperable. Targeted therapy may be an option in treatment of refractory cases.
Authors: Victor Wong; Dean Pavlick; Tim Brennan; Roman Yelensky; John Crawford; Jeffrey S Ross; Vincent A Miller; Denise Malicki; Philip J Stephens; Siraj M Ali; Hyunah Ahn Journal: J Natl Cancer Inst Date: 2015-11-12 Impact factor: 13.506
Authors: S L Gooskens; M E Houwing; G M Vujanic; J S Dome; T Diertens; A Coulomb-l'Herminé; J Godzinski; K Pritchard-Jones; N Graf; M M van den Heuvel-Eibrink Journal: Pediatr Blood Cancer Date: 2017-01-26 Impact factor: 3.167
Authors: D Gaillard; R Bouvier; E Sonsino; L Boccon Gibod; F Jaubert; C Nezelof; C Scheiner; A Lallemand; D Ploton Journal: Pediatr Pathol Date: 1992 Nov-Dec
Authors: Li Lei; Bradley A Stohr; Stacey Berry; Christina M Lockwood; Jessica L Davis; Erin R Rudzinski; Christian A Kunder Journal: Pract Lab Med Date: 2020-05-16